How to Buy Delcath Systems Stock
Delcath Systems Inc
Delcath Systems, Inc. , an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
Delcath Systems stock last closed at $10.89, down 2.07% from the previous day, and has increased 19.41% in one year. It has overperformed other stocks in the Medical Devices industry by 0.52 percentage points. Delcath Systems stock is currently +34.78% from its 52-week low of $8.08, and -40.26% from its 52-week high of $18.23.
As of Aug 25, 2025, there are 34.98M shares of DCTH outstanding. The market cap of DCTH is $380.95M. In the past 24 hours, 695,000 DCTH shares were traded.
How to Buy Delcath Systems Stock
Not sure how to invest in Delcath Systems stock? Here's how.
- Figure out where to buy Delcath Systems stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Delcath Systems stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Select your method of payment and add your information.
- Analyze Delcath Systems stock: The Delcath Systems ticker symbol is DCTH. Is Delcath Systems stock a good investment? Should you buy shares of DCTH? How do DCTH's underlying business fundamentals look? Do top analysts think Delcath Systems is a good buy? Why has DCTH's stock price moved recently? (Hint: Our stock analysis website can help you understand if DCTH is a good stock to buy).
- Make your DCTH buy order: Decide if you will purchase DCTH shares at the current market price or use a limit order to purchase DCTH shares at a given price.
- Get the latest scoop on your investment in DCTH: Create a watchlist to monitor your position in Delcath Systems stock.
Step 1: Figure out where to buy Delcath Systems stock
You will need an online brokerage account in order to access the NASDAQ market and buy DCTH stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal information so you can buy DCTH today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on our top ranked stock market app, you need to deposit funds:
Check out the video below for more details depositing funds into your brokerage account.
Step 4: Analyze Delcath Systems stock
After you have selected the best place to buy Delcath Systems stock, it's very important to research their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Delcath Systems quick stats
DCTH Overview
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on DCTH's stock page.
Is DCTH stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge DCTH's true value.
Using relative valuations metrics:
- DCTH may be overvalued based on its P/E ratio of 136.13x, relative to Medical Devices industry P/E ratio of 32.11x
- DCTH could be undervalued based on its P/B ratio of 3.63x, relative to Medical Devices industry P/B ratio of 4.04x
- DCTH may be undervalued based on its PEG ratio of 0.83x
You can access additional valuation analysis on DCTH's stock here.
How do DCTH Financials look?
Positive Health Checks:
- There are more short-term assets than long-term liabilities on the DCTH balance sheet.
- There are more short-term assets than short-term liabilities on the DCTH balance sheet.
- DCTH's operating cash flow of $4.85M allows it to safely service it's debt of $993.00k.
- DCTH profit margin has gone up from -474.2% to 3.2% in the past year.
- DCTH earnings of $1.26M is not enough to cover its interest payments.
- DCTH has a low debt to equity ratio of 0.11.
- Total DCTH debt is lower than 5 years ago, relative to shareholder equity.
Is Delcath Systems stock a Buy, Hold, or Sell, according to analysts?
Out of 2 sell side analysts who give forecasts on DCTH, the consensus analyst rating on Delcath Systems is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Delcath Systems stock forecast page.
Metrics for Advanced DCTH Traders
How are DCTH Revenues/Earnings doing?
Last year, DCTH revenue was $70.24M. During the past five year, DCTH's revenue has grown by 113.86% per year. This was faster than the Medical Devices industry average of 10.41%.
You can research DCTH's earnings and revenue performance here.
What are DCTH insiders up to?
Over the past year, insiders at DCTH have bought more shares than they have sold.
Vojo Vukovic, CHIEF MEDICAL OFFICER of DCTH, was the latest DCTH insider to buy. They bought $200,760.00 worth of DCTH stock on Jun 12, 2025.
Research more about who owns DCTH stock here.
Can I rely on DCTH as an income stream?
No, Delcath Systems doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your DCTH buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given price, place a limit order.
Click the Open Trade button and your broker will place your order.
If you require more help with buying stocks on eToro, click the helpful video below:
Step 6: Get the latest scoop on your investment in DCTH
Now that you own some DCTH stock, you'll want to stay up-to-date on your investment.
Add DCTH to a watchlist to get notified of the latest news about your DCTH stock.
DCTH Feed
No news
There is no news on the companies in your watchlist or you don't have enough companies added to your list.
How to Buy Stock in Delcath Systems
To summarize, here are the 6 steps to buy Delcath Systems stock:
- Figure out where to buy Delcath Systems stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Delcath Systems stock
- Make your DCTH buy order
- Get the latest scoop on your investment in DCTH
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Delcath Systems, click below.
Other Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.